Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (18)

2024

  1. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

  2. Stratification tools in the follow-up of people living with HIV, are they necessary and applicable?

    Farmacia Hospitalaria

2023

  1. Lipid profile changes associated with antiretroviral therapies in a real-world cohort

    Farmacia Hospitalaria, Vol. 47, Núm. 5, pp. 210-217

  2. Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e652-e660

  3. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 5, pp. 382-396

  4. Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226

2022

  1. Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211

  2. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  3. Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV

    AIDS, Vol. 36, Núm. 5, pp. 691-695

  4. Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

    Frontiers in immunology, Vol. 13, pp. 873408

2021

  1. Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection

    Medicine, Vol. 100, Núm. 46, pp. e27838

  2. Recent infections among newly diagnosed cases of HIV infection in Spain, 2015–2016. National estimates using cohort data

    Infectious Diseases, Vol. 53, Núm. 6, pp. 440-449

2020

  1. Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 1 e, pp. E41-E47

  2. Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients

    International Journal of STD and AIDS, Vol. 31, Núm. 5, pp. 467-473

  3. Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019

    Internal and Emergency Medicine

2016

  1. Lung cancer in HIV-infected patients

    AIDS Reviews, Vol. 18, Núm. 3, pp. 138-144

2014

  1. Invaginación ileocólica en un paciente infectado por el virus de la inmunodeficiencia humana

    Gastroenterologia y Hepatologia

2011

  1. Clinical experience with linezolid for the treatment of neurosurgical infections.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 24, Núm. 1, pp. 42-47